Readability & Display

Unofficial consolidated textConsolidated 2025-01-10English

Article 5

Reproduced from official EUR-Lex 10/1/2025.

Official catalogue · non-binding

Related guidance (9)

Current English catalogue entries that refer to Article 5. Guidance is non-binding and kept separate from the regulation text.

Browse topics
MDCG 2025-5Questions & Answers regarding performance studies of in vitro diagnostic medical devices under regulation (EU) 2017/746June 2025
MDCG 2024-10Clinical evaluation of orphan medical devicesJune 2024
MDCG 2023-1Guidance on the health institution exemption under Article 5(5) of Regulation (EU) 2017/745 and Regulation (EU) 2017/746January 2023
MDCG 2024-4 MDCG 2024-4 AppendixSafety reporting in performance studies of in vitro diagnostic medical devices under Regulation (EU) 2017/746Appendix – Performance Study Summary Safety Reporting FormApril 2024
MDCG 2022-10Q&A on the interface between Regulation (EU) 536/2014 on clinical trials for medicinal products for human use (CTR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR)May 2022
MDCG 2022-8Regulation (EU) 2017/746 - application of IVDR requirements to ‘legacy devices’ and to devices placed on the market prior to 26 May 2022 in accordance with Directive 98/79/ECMay 2022
MDCG 2025–10Guidance on post-market surveillance of medical devices and in vitro diagnostic medical devicesDecember 2025
MDCG 2021-5 rev.1Guidance on standardisation for medical devicesJuly 2024
Show all 9 guidance documentsShow only the first 8
Q&AQ&A on practical aspects related to the implementation of the extended transitional period provided for in the IVDR, as amended by Regulation (EU) 2024/1860July 2024

Reader references